phone fax
Los Angeles: Fri 07:40 - New York: Fri 10:40 - London: Fri 15:40 - Moscow: Fri 18:40 - Hyderãbãd: Fri 20:10 - Beijing: Fri. 23:40 - Tokyo: Fri 23:40


Are you Interested in more than 1 Lobby? Contact Us
MULTIPLE LOBBY SUBSCRIPTIONS
1 lobby @ $149 per user
2-5 lobbies @ $99 per lobby
6-9 lobbies @ $79 per lobby
GOLD SUBSCRIPTION
Full access to all lobbies for a whole year @ $700 per user

Pharmaceuticals Lobby
FREE WITH LOBBY ACCESS
FREE Newsfeed
FREE Extra Sections
FREE Quarterly Updates
Access for 365 Days
PowerPoint Slides of Report

Pharmaceuticals Lobby

You’re looking for information on Pharmaceuticals Lobby industry.
Finding reliable information on the global pharmaceutical industry can be either time consuming or very expensive. reportSURE's global pharmaceutical survey helps in both these cases. It covers trends, size, growth and segmentation at a global and regional level and provides detailed information on the top ten companies in the market. For a more detailed indication of what is included, see the table of contents and list of figures.

See: Table of contents | Contents PDF | List Of figures| List of tables | What is a Lobby

Published 2006

COMPLETE Pharma Survey + FULL LOBBY ACCESS
Get instant access to this Survey by buying Full Lobby Access for one year NOW. You get: The Full Survey with ALL sections below, all updates and the PowerPoint Slides.

NEWS November 6 - Pharmaceutical Industry Slated by Former Intel CEO

 

Former Intel CEO Andrew S. Grove had a few scathing words to say to the pharmaceutical industry. While with Intel, he saw the number of transistors on a chip grow from 1000 to nearly 10 billion, but treatments for major diseases like Parkinson’s are exactly the same today as they were 12 years ago. In the semiconductor industry, when a device can’t be made the same way twice; they investigate the cause. If this had not been done in at least one case, breakthroughs allowing many of the electronics devices we enjoy today may have never happened or would have at least been delayed greatly. In the pharma industry, when a batch of drugs tested doesn’t provide results better than the results of a placebo group the entire batch is rejected with no research into the cause of why the drug didn’t work. Opportunities are being missed.


 



© 2004, 2010 reportSURE Ltd All rights reserved